Use and abuse of oxytocic agents.
D001794:Blood Pressure / Q000187:drug effects; D001940:Breast / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004359:Drug Therapy, Combination; D004874:Ergonovine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D006982:Hypertonic Solutions; D007263:Infusions, Parenteral; D007668:Kidney / Q000187:drug effects; D007751:Labor, Induced; D008755:Methylergonovine / Q000009:adverse effects / Q000627:therapeutic use; D010120:Oxytocics / Q000627:therapeutic use*; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011247:Pregnancy; D012965:Sodium Chloride / Q000627:therapeutic use; D013034:Sparteine / Q000009:adverse effects / Q000627:therapeutic use; D019966:Substance-Related Disorders; D014554:Urination / Q000187:drug effects; D014869:Water Intoxication / Q000139:chemically induced
D006982:Hypertonic Solutions; D010120:Oxytocics; D013034:Sparteine; D012965:Sodium Chloride; D010121:Oxytocin; D008755:Methylergonovine; D004874:Ergonovine